OncoImmunology, 2162-4011

Journal

More filtering options
  1. 2020
  2. 2019
  3. Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

    Anna Kreutzman, Bhagwan Yadav, Tim H. Brummendorf, Bjorn Tore Gjertsen, Moon Lee Hee, Jeroen Janssen, Tiina Kasanen, Perttu Koskenvesa, Kourosh Lofti, Berit Markevärn, Ulla Olsson-Strömberg, Jesper Stentoft, Leif Stenke, Stina Söderlund, Lene Udby, Johan Richter, Henrik Hjorth-Hansen & Satu Mustjoki, 2019 Jul 13, In : OncoImmunology. 8, 9, e1638210.

    Research output: Contribution to journalArticle

  4. Immunoprofiles of colorectal cancer from Lynch syndrome

    Joanna Walkowska, Thomas Kallemose, Göran Jönsson, Mats Jönsson, Ove Andersen, Mads Hald Andersen, Inge Marie Svane, Anne Langkilde, Mef Nilbert & Christina Therkildsen, 2019, In : OncoImmunology. 8, 1, e1515612.

    Research output: Contribution to journalArticle

  5. 2018
  6. Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer

    Alexios Matikas, John Lövrot, Anna Ramberg, Margareta Eriksson, Therese Lindsten, Tobias Lekberg, Ingrid Hedenfalk, Niklas Loman, Jonas Bergh, Thomas Hatschek, Ann Erlandsson & Theodoros Foukakis, 2018, In : OncoImmunology. 7, 9, e1466017.

    Research output: Contribution to journalArticle

  7. Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses

    Jasmin Quandt, Christoph Schlude, Michael Bartoschek, Rainer Will, Angel Cid-Arregui, Sebastian Schölch, Christoph Reissfelder, Jürgen Weitz, Martin Schneider, Stefan Wiemann, Frank Momburg & Philipp Beckhove, 2018, In : OncoImmunology. 7, 12, e1500671.

    Research output: Contribution to journalArticle

  8. Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment

    Christina Mertens, Javier Mora, Bilge Ören, Stephan Grein, Sofia Winslow, Klaus Scholich, Andreas Weigert, Per Malmström, Carina Forsare, Mårten Fernö, Tobias Schmid, Bernhard Brüne & Michaela Jung, 2018, In : OncoImmunology. 7, 3, e1408751.

    Research output: Contribution to journalArticle

  9. 2015
  10. Kick-starting the cancer-immunity cycle by targeting CD40

    Peter Ellmark, S. M. Mangsbo, C. Furebring, T. H. Totterman & P. Norlen, 2015, In : OncoImmunology. 4, 7, p. e1011484

    Research output: Contribution to journalDebate/Note/Editorial

  11. Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia.

    Anna Martner, Anna Rydström, Rebecca E Riise, Johan Aurelius, Harald Anderson, Mats Brune, Robin Foà, Kristoffer Hellstrand & Fredrik B Thorén, 2015, In : OncoImmunology. 5, 1, p. e1041701

    Research output: Contribution to journalArticle

  12. 2014
  13. Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo.

    Linda C Sandin, Fredrik Eriksson, Peter Ellmark, Angelica Si Loskog, Thomas H Tötterman & Sara M Mangsbo, 2014, In : OncoImmunology. 3, 1, p. e27614

    Research output: Contribution to journalArticle

  14. Toll-like receptor genetic variants and colorectal cancer.

    Alexander Nr Weber & Asta Försti, 2014, In : OncoImmunology. 3, 1, p. e27763

    Research output: Contribution to journalDebate/Note/Editorial

  15. 2012
  16. S100A9 and tumor growth.

    Tomas Leanderson & Fredrik Ivars, 2012, In : OncoImmunology. 1, 8, p. 1404-1405

    Research output: Contribution to journalArticle